Standardizing mammogram screening in primary care: Integrating an evidence-based approach.
Journal
Journal of the American Association of Nurse Practitioners
ISSN: 2327-6924
Titre abrégé: J Am Assoc Nurse Pract
Pays: United States
ID NLM: 101600770
Informations de publication
Date de publication:
09 Jun 2020
09 Jun 2020
Historique:
received:
04
12
2019
accepted:
21
02
2020
pubmed:
17
6
2020
medline:
25
11
2021
entrez:
17
6
2020
Statut:
epublish
Résumé
Mammogram screening for surveillance and detection of breast cancer has been long recognized as a preventive health measure in primary care for women. However, a clear consensus on when to start screening individual women, based on age and risk factors, lacks guidance. Reputable organizations uphold varying breast cancer screening (BCS) guidelines for women potentiating the risk for fragmented and inconsistent practices among health care providers (HCPs). This review aims to evaluate the current literature on the possible risks, benefits, and limitations associated with BCS for women between 40 and 49 years and to discuss the need for a more individualized, evidence-based approach to BCS. A comprehensive systematic review of eight articles, along with five clinical practice guidelines published within the past 10 years that address advantages and disadvantages of receiving mammography for women in their fourth decade was completed. There is insufficient evidence to promote adherence to any single clinical practice guideline for the benefit of all patients. Further high-level research is needed, as well as the assessment of individual risk factors influencing breast cancer development and screening outcomes. There is a significant need for further education for HCPs and the development of tools that incorporate a BCS shared decision-making process. Current practice lacks the ability to easily screen individual patients with a method that identifies the appropriate age to screen and addresses the benefits, risks, and limitations of mammography.
Sections du résumé
BACKGROUND
BACKGROUND
Mammogram screening for surveillance and detection of breast cancer has been long recognized as a preventive health measure in primary care for women. However, a clear consensus on when to start screening individual women, based on age and risk factors, lacks guidance. Reputable organizations uphold varying breast cancer screening (BCS) guidelines for women potentiating the risk for fragmented and inconsistent practices among health care providers (HCPs).
OBJECTIVES
OBJECTIVE
This review aims to evaluate the current literature on the possible risks, benefits, and limitations associated with BCS for women between 40 and 49 years and to discuss the need for a more individualized, evidence-based approach to BCS.
DATA SOURCES
METHODS
A comprehensive systematic review of eight articles, along with five clinical practice guidelines published within the past 10 years that address advantages and disadvantages of receiving mammography for women in their fourth decade was completed.
CONCLUSIONS
CONCLUSIONS
There is insufficient evidence to promote adherence to any single clinical practice guideline for the benefit of all patients. Further high-level research is needed, as well as the assessment of individual risk factors influencing breast cancer development and screening outcomes.
IMPLICATIONS FOR PRACTICE
CONCLUSIONS
There is a significant need for further education for HCPs and the development of tools that incorporate a BCS shared decision-making process. Current practice lacks the ability to easily screen individual patients with a method that identifies the appropriate age to screen and addresses the benefits, risks, and limitations of mammography.
Identifiants
pubmed: 32541577
pii: 01741002-202109000-00006
doi: 10.1097/JXX.0000000000000418
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
688-697Informations de copyright
Copyright © 2020 American Association of Nurse Practitioners.
Déclaration de conflit d'intérêts
Competing interests: The authors report no conflicts of interest.
Références
American Cancer Society. (2017). Breast cancer facts & figures 2017–2018. Retrieved from https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/breast-cancer-facts-and-figures-2017-2018.pdf.
American Cancer Society. (2020). How common is breast cancer? Retrieved from https://www.cancer.org/cancer/breast-cancer/about/how-common-is-breast-cancer.html.
Bevers T. B., Helvie M., Bonaccio E., Calhoun K. E., Daly M. B., Farrar W. B., Garber J. E., Gray R., Greenberg C. C., Greenup R., Hansen N. M., Harris R. E., Heerdt A. S., Helsten T., Hodgkiss L., Hoyt T. L., Huff J. G., Jacobs L., Lehman C. D., Monsees B., Kumar R. (2018). Breast cancer screening and diagnosis, version 3.2018, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network: JNCCN, 16, 1362–1389.
Breastcancer.org. (2019). U.S. breast cancer statistics. Retrieved from https://www.breastcancer.org/symptoms/understand_bc/statistics.
Centers for Disease Control and Prevention. (2019). Breast cancer awareness. Retrieved from https://www.cdc.gov/cancer/dcpc/resources/features/breastcancerawareness/.
Daly M. B., Pilarski R., Berry M., Buys S. S., Farmer M., Friedman S., Garber J. E., Kauff N. D., Khan S., Klein C., Kohlmann W., Kurian A., Litton J. K., Madlensky L., Merajver S. D., Offit K., Pal T., Reiser G., Shannon K. M., Swisher E., Darlow S. (2017). NCCN guidelines insights: Genetic/familial high-risk assessment: Breast and ovarian, version 2.2017. Journal of the National Comprehensive Cancer Network: JNCCN, 15, 9–20.
Electronic Clinical Quality Improvement Resource Center. (2018). Breast cancer screening. Retrieved from https://ecqi.healthit.gov/ecqm/measures/cms125v6.
Lee C. H., Dershaw D. D., Kopans D., Evans P., Monsees B., Monticciolo D., James Brenner R., Bassett L., Berg W., Feig S., Hendrick E., Mendelson E., D'Orsi C., Sickles E., Burhenne L. W. (2010). Breast cancer screening with imaging: Recommendations from the society of breast imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. Journal of the American College of Radiology, 7, 18–27.
Magnus M. C., Ping M., Shen M. M., Bourgeois J., Magnus J. H. (2011). Effectiveness of mammography screening in reducing breast cancer mortality in women aged 39–49 years: A meta-analysis. Journal of Women's Health, 20, 845–852.
Monticciolo D. L., Newell M. S., Hendrick R. E., Helvie M. A., Moy L., Monsees B., Kopans D. B., Eby P. R., Sickles E. A. (2017). Breast cancer screening for average-risk women: Recommendations from the ACR commission on breast imaging. Journal of the American College of Radiology, 14, 1137–1143.
Moyer V. A. (2014). Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. preventive services task force recommendation statement. Annals of Internal Medicine, 160, 271.
Myers E. R., Moorman P., Gierisch J. M., Havrilesky L. J., Grimm L. J., Ghate S., Davidson B., Mongtomery R. C., Crowley M. J., McCrory D. C., Kendrick A., Sanders G. D. (2015). Benefits and harms of breast cancer screening: A systematic review. JAMA, 314, 1615–1634.
National Cancer Institute. (n.d.). NCI dictionary of cancer terms. Retrieved from https://www.cancer.gov/publications/dictionaries/cancer-terms/def/overdiagnosis.
Nelson H. D., Fu R., Cantor A., Pappas M., Daeges M., Humphrey L. (2016a). Effectiveness of breast cancer screening: Systematic review and meta-analysis to update the 2009 U.S. preventive services task force recommendation. Annals of Internal Medicine, 164, 244.
Nelson H. D., Pappas M., Cantor A., Griffin J., Daeges M., Humphrey L. (2016b). Harms of breast cancer screening: Systematic review to update the 2009 U.S. preventive services task force recommendation. Annals of Internal Medicine, 164, 256.
Oeffinger K. C., Fontham E. T. H., Etzioni R., Herzig A., Michaelson J. S., Shih Y. T., Walter L. C., Church T. R., Flowers C. R., LaMonte S. J., Wolf A. M. D., DeSantis C., Lortet-Tieulent J., Andrews K., Manassaram-Baptiste D., Saslow D., Smith R. A., Brawley O. W., Wender R., & American Cancer Society. (2015). Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA, 314, 1599–1614.
Pace L. E., Keating N. L. (2014). A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA, 311, 1327–1335.
Shen N., Hammonds L., Madsen D., Dale P. (2011). Mammography in 40-year-old women: What difference does it make? The potential impact of the U.S. preventative services task force (USPSTF) mammography guidelines. Annals of Surgical Oncology, 18, 3066–3071.
Siu A. L. (2016). Screening for breast cancer: U.S. preventive services task force recommendation statement. Annals of Internal Medicine, 164, 279.
Surveillance, Epidemiology, and End Results Program. (n. d.). Cancer stat facts: Female breast cancer. Retrieved from https://seer.cancer.gov/statfacts/html/breast.html.
American College of Obstetricians and Gynecologists. (2017). ACOG practice bulletin: Clinical management guidelines for obstetrician-gynecologists. Retrieved from https://www.acog.org/Clinical-Guidance-and-Publications/Practice-Bulletins/Committee-on-Practice-Bulletins-Gynecology/Breast-Cancer-Risk-Assessment-and-Screening-in-Average-Risk-Women?IsMobileSet=false.
van den Ende C., Oordt‐Speets A. M., Vroling H., van Agt H. M. E. (2017). Benefits and harms of breast cancer screening with mammography in women aged 40–49 years: A systematic review. International Journal of Cancer, 141, 1295–1306.
World Health Organization. (2018). Breast cancer: Prevention and control. Retrieved from http://www.who.int/cancer/detection/breastcancer/en/index1.html.